Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • D'Lima, Darryl
  • Venn-Watson, E. J.
  • Tripuraneni, P.
  • Colwell Jr., Clifford

publication date

  • December 2001

journal

  • Orthopedics  Journal

abstract

  • This study compared the efficacy and cost of radiation therapy with indomethacin in the prophylaxis of heterotopic ossification following total hip replacement. Twenty-two patients received a radiation dose of 10 Gy in five fractions, 28 patients 8 Gy in one fraction, and 27 patients 25 mg oral indomethacin three times a day for either 7 or 21 days. Patients at higher risk for heterotopic ossification were more likely to receive radiation therapy than indomethacin. At a mean follow-up of 2 years, there were no differences in failure rates between the high-risk patients treated with radiation and the low-risk patients treated with indomethacin. Currently, the patient-billed cost of radiation is $1400 whereas the cost for indomethacin is approximately $100. Indomethacin appears to be as effective as radiation therapy in patients at low to moderate risk for heterotopic ossification and offers significant cost savings.

subject areas

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal
  • Arthroplasty, Replacement, Hip
  • Female
  • Health Care Costs
  • Humans
  • Indomethacin
  • Male
  • Middle Aged
  • Ossification, Heterotopic
  • Radiotherapy
  • Retrospective Studies
  • Risk Factors
  • Treatment Failure
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0147-7447

PubMed ID

  • 11770090
scroll to property group menus

Additional Document Info

start page

  • 1139

end page

  • 1143

volume

  • 24

issue

  • 12

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support